<DOC>
	<DOCNO>NCT02890147</DOCNO>
	<brief_summary>Connective tissue disease ( CTD ) systemic autoimmune disease ( SADs ) know today group chronic inflammatory condition autoimmune aetiology treatment option difficult diagnosis.Brest team contribute perform new classification follow systemic autoimmune disease European Union 's Seventh Framework Programme . The aim research constitute Healthy Volunteers cohort compare systemic autoimmune disease cohort molecular cluster instead clinical entity determination molecular profile use several `` Omics '' technique .</brief_summary>
	<brief_title>Molecular Reclassification Find Clinically Useful Biomarkers Systemic Autoimmune Diseases : Case-control</brief_title>
	<detailed_description>The main objective PRECISESADS project reclassify individual affect SADs molecular cluster instead clinical entity determination molecular profile use several `` -omics '' technique . The specific objective cross sectional study sub-study : 1 . To identify systemic taxonomy patient SADs produce follow data individual SADs control : genetic , epigenomic , transcriptomic , flow cytometric ( peripheral blood mononuclear polymorphonuclear cell ( PBMCs ) ) , metabolomics proteomic plasma urine , exosome analysis , classical serology ( antibody autoantibody ) , clinical data . 2 . To good characterize individual SADs omics level . 3 . To perform clustering analysis determine group individual , differentially group , share specific molecular feature ( precision medicine ) . 4 . To identify gene expression , methylation profile deconvolution method compare mixture cell subpopulation determine flow cytometry separate cell , cytokine profile plasma metabolomics use Mass Spectrometry , substudy 288 individual . The cluster process data-driven aim find homogenous differentiated cluster diseases clearly separate individual basis , serological , genetic , epigenomic , cellular ( cell proportion ) , metabolomic , proteomic ( cytokine , autoantibody ) transcriptome characteristic differentiate control patient cluster . A total 2000 patient 666 control include study .</detailed_description>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<criteria>Aged 18 year old time consent Signed informed consent form Individuals chronic medication . Individuals suffer inflammatory , autoimmune , allergic infectious condition possible without history autoimmune disease , particularly thyroid disease disease may modify cellular profile blood . Pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>SADs</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Molecular profile</keyword>
	<keyword>Omics Techniques</keyword>
</DOC>